TY - JOUR
T1 - Anti-inflammatory and antibacterial activity constituents from the stem of Cinnamomum validinerve
AU - Yang, Chi Lung
AU - Wu, Ho Cheng
AU - Hwang, Tsong Long
AU - Lin, Chu Hung
AU - Cheng, Yin Hua
AU - Wang, Chia Chi
AU - Kan, Hung Lin
AU - Kuo, Yueh Hsiung
AU - Chen, Ih Sheng
AU - Chang, Hsun Shuo
AU - Lin, Ying Chi
N1 - Funding Information:
Funding: This study was supported by the Ministry of Science and Technology, R.O.C. (MOST 109-2628-B-037-015), and Kaohsiung Medical University’s grant (KMU-TC108A03-8, KMU-TC108A03-9, and KMU-M108014) Acknowledgments: We thank the Center for Research Resources and Development of Kaohsiung Medical University for providing a nuclear magnetic resonance (NMR) spectrometer, and also senior technician Chyi-Jia Wang for measuring the 2D NMR data.
Publisher Copyright:
© 2020 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2020/8
Y1 - 2020/8
N2 - One new dibenzocycloheptene, validinol (1), and one butanolide firstly isolated from the natural source, validinolide (2), together with 17 known compounds were isolated from the stem of Cinnamomum validinerve. Among the isolates, lincomolide A (3), secosubamolide (7), and cinnamtannin B1 (19) exhibited potent inhibition on both superoxide anion generation (IC50 values of 2.98 ± 0.3 µM, 4.37 ± 0.38 µM, and 2.20 ± 0.3 µM, respectively) and elastase release (IC50 values of 3.96 ± 0.31 µM, 3.04 ± 0.23 µM, and 4.64 ± 0.71 µM, respectively) by human neutrophils. In addition, isophilippinolide A (6), secosubamolide (7), and cinnamtannin B1 (19) showed bacteriostatic effects against Propionibacterium acnes in in vitro study, with minimal inhibitory concentration (MIC) values at 16 µg/mL, 16 µg/mL, and 500 µg/mL, respectively. Further investigations using the in vivo ear P. acnes infection model showed that the intraperitoneal administration of the major component cinnamtannin B1 (19) reduced immune cell infiltration and pro-inflammatory cytokines TNF-α and IL-6 at the infection sites. The results demonstrated the potential of cinnamtannin B1 (19) for acne therapy. In summary, these results demonstrated the anti-inflammatory potentials of Formosan C. validinerve during bacterial infections.
AB - One new dibenzocycloheptene, validinol (1), and one butanolide firstly isolated from the natural source, validinolide (2), together with 17 known compounds were isolated from the stem of Cinnamomum validinerve. Among the isolates, lincomolide A (3), secosubamolide (7), and cinnamtannin B1 (19) exhibited potent inhibition on both superoxide anion generation (IC50 values of 2.98 ± 0.3 µM, 4.37 ± 0.38 µM, and 2.20 ± 0.3 µM, respectively) and elastase release (IC50 values of 3.96 ± 0.31 µM, 3.04 ± 0.23 µM, and 4.64 ± 0.71 µM, respectively) by human neutrophils. In addition, isophilippinolide A (6), secosubamolide (7), and cinnamtannin B1 (19) showed bacteriostatic effects against Propionibacterium acnes in in vitro study, with minimal inhibitory concentration (MIC) values at 16 µg/mL, 16 µg/mL, and 500 µg/mL, respectively. Further investigations using the in vivo ear P. acnes infection model showed that the intraperitoneal administration of the major component cinnamtannin B1 (19) reduced immune cell infiltration and pro-inflammatory cytokines TNF-α and IL-6 at the infection sites. The results demonstrated the potential of cinnamtannin B1 (19) for acne therapy. In summary, these results demonstrated the anti-inflammatory potentials of Formosan C. validinerve during bacterial infections.
KW - Anti-acne activity
KW - Anti-inflammatory activity
KW - Cinnamomum validinerve
KW - Lauraceae
UR - http://www.scopus.com/inward/record.url?scp=85088810560&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088810560&partnerID=8YFLogxK
U2 - 10.3390/molecules25153382
DO - 10.3390/molecules25153382
M3 - Article
C2 - 32722482
AN - SCOPUS:85088810560
SN - 1420-3049
VL - 25
JO - Molecules
JF - Molecules
IS - 15
M1 - 3382
ER -